What’s the Difference Between Zepbound & Mounjaro?
Zepbound and Mounjaro are essentially the same medication, with the same active ingredient, tirzepatide. However, they are approved for different medical conditions. Zepbound is approved for chronic weight management, while Mounjaro is approved for type 2 diabetes.
Here is a table summarizing the key differences between Zepbound and Mounjaro:
As you can see, the two medications are very similar in terms of their active ingredient, dosage, and cost. The only real difference is their FDA approval. Zepbound is specifically approved for weight loss, while Mounjaro is specifically approved for type 2 diabetes. However, both medications can be used off-label for the other condition.
Here is a more detailed explanation of how Zepbound and Mounjaro work:
Both Zepbound and Mounjaro work by targeting two hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). GLP-1 and GIP are naturally produced in the gut, and they help to regulate blood sugar levels and promote satiety.
Zepbound and Mounjaro work by mimicking the effects of GLP-1 and GIP. This leads to a number of benefits, including:
- Increased satiety, which can help people eat less and feel full sooner
- Reduced appetite
- Improved blood sugar control
- Weight loss
It is important to note that Zepbound and Mounjaro are not a magic bullet for weight loss. They are most effective when used in combination with lifestyle changes, such as diet and exercise.
If you are considering using Zepbound or Mounjaro, talk to your doctors office about whether it is right for you.